Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties
| Autor: | Leslie R Lamb, Marc D. Succi, Dexter P. Mendoza, Helen Anne D'Alessandro, Avinash Kambadakone, Constance D. Lehman |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pediatrics
medicine.medical_specialty COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) Population Lymphadenopathy Context (language use) 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Radiologists Pandemic Axillary Lymphadenopathy medicine Humans Radiology Nuclear Medicine and imaging Stage (cooking) education education.field_of_study SARS-CoV-2 business.industry Vaccination COVID-19 Cancer medicine.disease primary health care 030220 oncology & carcinogenesis oncology Original Article business |
| Zdroj: | Journal of the American College of Radiology |
| ISSN: | 1546-1440 |
| DOI: | 10.1016/j.jacr.2021.03.001 |
| Popis: | Reports are rising of patients with unilateral axillary lymphadenopathy, visible on diverse imaging examinations, after recent coronavirus disease 2019 vaccination. With less than 10% of the US population fully vaccinated, we can prepare now for informed care of patients imaged after recent vaccination. The authors recommend documenting vaccination information (date[s] of vaccination[s], injection site [left or right, arm or thigh], type of vaccine) on intake forms and having this information available to the radiologist at the time of examination interpretation. These recommendations are based on three key factors: the timing and location of the vaccine injection, clinical context, and imaging findings. The authors report isolated unilateral axillary lymphadenopathy (i.e., no imaging findings outside of visible lymphadenopathy), which is ipsilateral to recent (prior 6 weeks) vaccination, as benign with no further imaging indicated. Clinical management is recommended, with ultrasound if clinical concern persists 6 weeks after the final vaccination dose. In the clinical setting to stage a recent cancer diagnosis or assess response to therapy, the authors encourage prompt recommended imaging and vaccination (possibly in the thigh or contralateral arm according to the location of the known cancer). Management in this clinical context of a current cancer diagnosis is tailored to the specific case, ideally with consultation between the oncology treatment team and the radiologist. The aim of these recommendations is to (1) reduce patient anxiety, provider burden, and costs of unnecessary evaluation of enlarged nodes in the setting of recent vaccination and (2) avoid further delays in vaccinations and recommended imaging for best patient care during the pandemic. Visual Abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|